Retacrit

Comprehensive physicochemical characterization and biological assays are essential parts in assessing quality attributes of… (More)

The World Health Organization defines a biosimilar as "a biotherapeutic product which is similar in terms of quality, safety and… (More)

INTRODUCTION Chemotherapy-induced anemia (CIA) is a frequent complication among cancer patients, with elderly patients more… (More)

INTRODUCTION There is an essential need for clinicians to understand the development and approval process of biosimilars… (More)

INTRODUCTION A "biosimilar" or "similar biological medicinal product" is a biological agent that is similar in terms of quality… (More)

To compare the quality of therapeutic erythropoietin (EPO) products, including two biosimilars, with respect to content… (More)

This first phase of the first generation of modern biotechnology-derived protein drugs is now coming to an end with the… (More)

This year will see the first serious engagements in the biogenerics war, as two copycat versions of the world’s biggest-selling… (More)

Two patients with thalassemia minor and end-stage renal failure on hemodialysis were treated with epoetin zeta (Silapo, Retacrit… (More)